Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
121 participants
OBSERVATIONAL
2020-03-06
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
JETi Lower Extremity Arterial Thrombosis
NCT04370691
JETi Hong Kong Post Market Study (PMS)
NCT06340763
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
NCT02414802
Compression Aided Management of Edema in Patients With C3 Venous Disease
NCT00766974
Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients
NCT05347550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
JETi™ Hydrodynamic Thrombectomy System
Subjects who were treated with JETi™ Hydrodynamic Thrombectomy System were included.
JETi lower extremity venous thrombosis
The JETi System is a hydro-mechanical aspiration system, intended for the removal of intravascular thrombus. The system comprises of the JETi Catheter (6F or 8F), JETi Pump Set, JETi Saline Drive Unit (SDU), JETi Accessory Cart, JETi Suction tubing and JETi Non-Sterile Canister Set. The JETi System is designed to continuously aspirate thrombotic material into the catheter, where a high-pressure stream of saline within the catheter tip macerates the thrombus as it is aspirated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
JETi lower extremity venous thrombosis
The JETi System is a hydro-mechanical aspiration system, intended for the removal of intravascular thrombus. The system comprises of the JETi Catheter (6F or 8F), JETi Pump Set, JETi Saline Drive Unit (SDU), JETi Accessory Cart, JETi Suction tubing and JETi Non-Sterile Canister Set. The JETi System is designed to continuously aspirate thrombotic material into the catheter, where a high-pressure stream of saline within the catheter tip macerates the thrombus as it is aspirated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject or legally authorized representative must provide written informed consent.
3. Subject must be ≥ 18 years of age.
Exclusion Criteria
2. Subject is currently participating in another drug or device clinical investigation.
3. Subject has active symptoms and/or a positive test result of COVID-19 or other rapidly spreading novel infectious agent within the past 20 days.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HonorHealth
Scottsdale, Arizona, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
PIH Good Samaritan
Los Angeles, California, United States
Cedars Sinai Medical Center
Los Angeles, California, United States
Stanford University Hospital and Clinics
Palo Alto, California, United States
University of Colorado
Aurora, Colorado, United States
ClinRé
Thornton, Colorado, United States
St. Mary Medical Center
Hobart, Indiana, United States
Midwest Cardiovascular Research Foundation
Davenport, Iowa, United States
University of Louisville
Louisville, Kentucky, United States
Southoast Hospital
Fall River, Massachusetts, United States
Henry Ford Detroit
Detroit, Michigan, United States
St. Luke's Hospital
Kansas City, Missouri, United States
Weill Cornell Medicine
New York, New York, United States
Mount Sinai Hospital
New York, New York, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Ascension St. John Jane Phillips
Bartlesville, Oklahoma, United States
Hightower Clinical
Oklahoma City, Oklahoma, United States
Hendrick Medical Center
Abilene, Texas, United States
University of Utah Hospital
Salt Lake City, Utah, United States
Charleston Area Medical Center
Charleston, West Virginia, United States
Royal Perth Hospital
Perth, , Australia
Hôpital Saint-François d'Assise
Québec, Quebec, Canada
University Hospital Aachen
Aachen, North Rhine-Westphalia, Germany
Marien Hospital Herne
Herne, North Rhine-Westphalia, Germany
Klinikum Hochsauerland
Arnsberg, , Germany
Evangelisches Krankenhaus Königin Elisabeth Herzberge
Berlin, , Germany
Sankt Gertrauden Krankenhaus
Berlin, , Germany
Medizinische Einrichtungen der Universität zu Köln
Cologne, , Germany
Universitätsklinikum Giessen
Giessen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABT-CIP-10433 Venous
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.